EventSpain set to unveil the potential of the b...The Spanish EU Council Presidency is to set the course for the internationally competitive use of biotechnology in drug development, plant breeding and food production. more ➔
financingMogrify Ltd extends Series A financing to...British in-vivo cell programming specialist Mogrify Ltd has added US$10m to its US$36m Series A financing. more ➔
RNAJoining forces for mRNA breakthroughDyadic International Inc. and bYoRNA SAS partnered to advance innovative bioproduction technologies for scaling up the production of therapeutic mRNA from C1-Cells. more ➔
FundingSeaBeLife secures €1.2m in fundingBiotech company, specialising in cell necrosis prevention, has announced a successful funding round, securing €1.2m in additional seed funding. more ➔
EventBioSpain breaking recordsWith more than 2,100 attendents, 4,700 partnering meetings so far, BioSpain 2023 is set to break records. more ➔
CollaborationPierre Fabre Laboratories collaborate with...Pierre Fabre Laboratories, a leading French medical and beauty care company and Vernalis (R&D) Ltd, a fully owned subsidiary of HitGen Inc. and a specialist in drug discovery announce a long-term … more ➔
NeurologyCrucible Therapeutics spins out with £5mUniversity of Sheffield spinout gets £5m for gene therapies targeting ALS and FTD, advancing towards clinical trials. more ➔
M&AOxford Biomedica acquires ABL Europe for ...Oxford Biomedica’s proposed acquisition of ABL Europe from Institut Mérieux, at a consideration of €15m propels global leadership in cell and gene therapy. more ➔
Austrian Kern Tec raises €12m in Series...Austrian Kern Tec GmbH has raised €12m in the biggest Series A financing ever seen for a foodtech company in Austria to scale food production from waste. more ➔
partnershipBenevolentAI Ltd inks US$594m partnership...British drug discovery specialist BenevolentAI Ltd has licenced its end-to-end AI platform capabilities to Merck KGaA to deliver novel drug candidates for three targets in oncology, neurology and im … more ➔
